-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Atara Biotherapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2013 to Q1 2025.
- Atara Biotherapeutics, Inc. Depreciation for the quarter ending March 31, 2025 was $300K, a 66.7% decline year-over-year.
- Atara Biotherapeutics, Inc. Depreciation for the twelve months ending March 31, 2025 was $300K, a 91.9% decline year-over-year.
- Atara Biotherapeutics, Inc. annual Depreciation for 2024 was $900K, a 75.7% decline from 2023.
- Atara Biotherapeutics, Inc. annual Depreciation for 2023 was $3.7M, a 21.3% decline from 2022.
- Atara Biotherapeutics, Inc. annual Depreciation for 2022 was $4.7M.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)